Fresenius Kabi India

Fresenius Kabi India is the Indian subsidiary of the German healthcare corporation, Fresenius Kabi. The company focuses on the development and production of specialized intravenous drugs, clinical nutrition, and oncology treatments for patients in India and various international markets. One of their formulations is listed here for reference.

Kabidarba 40 Injection

Kabidarba 40 Injection

Stimulates red blood cell production in your bone marrow to increase hemoglobin levels and support oxygen transport.

About Fresenius Kabi India

Fresenius Kabi India operates as a subsidiary of the Fresenius Kabi global organization, which maintains headquarters in Germany. The company specializes in the pharmaceutical segments of oncology, intravenous parenteral nutrition, and fluid therapy. Their manufacturing processes are designed to follow international safety standards required for the production of critical care and hospital-based medications.

The company maintains a significant presence in global markets, providing specialized formulations to the United States, United Kingdom, Australia, and Canada. By leveraging the technological expertise of their parent organization, they produce complex generic versions of sterile injectable medications. Their focus remains primarily on the hospital and clinical setting, ensuring that healthcare providers have access to reliable pharmaceutical solutions.

Fresenius Kabi India’s Product Range

The product range encompasses specialized therapies, particularly within oncology and intensive care settings. Their portfolio includes injectable formulations that require precise manufacturing environments. The item listed in this catalog, Kabidarba 40 Injection, is representative of their focus on delivering injectable therapeutic agents for clinical use.

Finding Fresenius Kabi India Products Online

  • Patients across the United States, United Kingdom, Australia, and Canada and similar markets search for Fresenius Kabi India products through online pharmacy directories when researching their prescribed medication’s manufacturer.
  • Individuals may verify the manufacturer of a specific intravenous or oncology medication before coordinating with their healthcare facility.
  • Researchers use this listing to identify available formulations produced by the company for specific therapeutic categories.
  • Patients often verify whether a specific generic injection is manufactured by this entity when comparing options provided in a clinical setting.

About the Products Listed

The product listed is a generic pharmaceutical formulation manufactured by Fresenius Kabi India. Individual products differ in active ingredient, formulation, strength, and intended use. This page is a product catalog — it is not medical advice or an endorsement of specific products. Readers should review individual product labeling and consult a healthcare professional for guidance on which product suits their needs.